These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Lessons learned from the maturation of a cancer drug: oxaliplatin in colorectal cancer. Glimelius B; Nygren P Acta Oncol; 2019 Apr; 58(4):395-397. PubMed ID: 30882261 [No Abstract] [Full Text] [Related]
29. Subcutaneous administration of amifostine: a promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy. Penz M; Kornek GV; Raderer M; Ulrich-Pur H; Fiebiger W; Scheithauer W Ann Oncol; 2001 Mar; 12(3):421-2. PubMed ID: 11332158 [No Abstract] [Full Text] [Related]
30. Prevention of Chemotherapy-Induced Peripheral Neuropathy by Inhibiting C-X-C Motif Chemokine Receptor 2. Cho HS; Choi YI; Park SU; Han YS; Kwon J; Jung SJ Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768178 [TBL] [Abstract][Full Text] [Related]
31. Early Neuropathy Related to Oxaliplatin Treatment in Advanced and Recurrent Colorectal Cancer. Nagata T; Fukuda KI; Tamai M; Taniguchi A; Kamiya H; Kambe K; Kamada Y; Iwata G; Yamaoka N Anticancer Res; 2019 Mar; 39(3):1347-1353. PubMed ID: 30842168 [TBL] [Abstract][Full Text] [Related]
32. Characterization of acute and chronic neuropathies induced by oxaliplatin in mice and differential effects of a novel mitochondria-targeted antioxidant on the neuropathies. Toyama S; Shimoyama N; Ishida Y; Koyasu T; Szeto HH; Shimoyama M Anesthesiology; 2014 Feb; 120(2):459-73. PubMed ID: 24064792 [TBL] [Abstract][Full Text] [Related]
33. Role of metformin in oxaliplatin-induced peripheral neuropathy in patients with stage III colorectal cancer: randomized, controlled study. El-Fatatry BM; Ibrahim OM; Hussien FZ; Mostafa TM Int J Colorectal Dis; 2018 Dec; 33(12):1675-1683. PubMed ID: 29931409 [TBL] [Abstract][Full Text] [Related]
35. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents. Ushio S; Egashira N; Sada H; Kawashiri T; Shirahama M; Masuguchi K; Oishi R Eur J Cancer; 2012 Jun; 48(9):1407-13. PubMed ID: 21907570 [TBL] [Abstract][Full Text] [Related]
36. TRPA1 and TRPM8 Receptors May Promote Local Vasodilation that Aggravates Oxaliplatin-Induced Peripheral Neuropathy Amenable to 17β-Estradiol Treatment. Pan Y; Chen F; Huang S; Cai Z; Lan H; Tong Y; Yu X; Zhao G Curr Neurovasc Res; 2016; 13(4):309-317. PubMed ID: 27262300 [TBL] [Abstract][Full Text] [Related]
37. Early changes in tests of peripheral nerve function during oxaliplatin treatment and their correlation with chemotherapy-induced polyneuropathy symptoms and signs. Krøigård T; Svendsen TK; Wirenfeldt M; Schrøder HD; Qvortrup C; Pfeiffer P; Gaist D; Sindrup SH Eur J Neurol; 2020 Jan; 27(1):68-76. PubMed ID: 31373417 [TBL] [Abstract][Full Text] [Related]
38. Oral administration of Cystine and Theanine ameliorates oxaliplatin-induced chronic peripheral neuropathy in rodents. Kawashiri T; Kobayashi D; Egashira N; Tsuchiya T; Shimazoe T Sci Rep; 2020 Jul; 10(1):12665. PubMed ID: 32728157 [TBL] [Abstract][Full Text] [Related]
39. Drug treatment for chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer. Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Okubo Y; Nakamura J; Takasumi M; Hashimoto M; Kato T; Kobashi R; Hikichi T; Ohira H Fukushima J Med Sci; 2022 Apr; 68(1):1-10. PubMed ID: 35197393 [TBL] [Abstract][Full Text] [Related]
40. [Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy]. Taguchi K Yakugaku Zasshi; 2016; 136(2):287-96. PubMed ID: 26831807 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]